Personalis to Present at the 21st Annual Morgan Stanley Global Healthcare Conference
29 Agosto 2023 - 5:01PM
Business Wire
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics
for precision oncology, announced today that its management team
will present at the 21st Annual Morgan Stanley Global Healthcare
Conference on Tuesday, September 12, 2023 at 4:55 p.m. Eastern Time
in New York, NY at the Sheraton New York.
About Personalis, Inc.
At Personalis, we are transforming the active management of
cancer through breakthrough personalized testing. We aim to drive a
new paradigm for cancer management, guiding care from biopsy
through the life of the patient. Our highly sensitive assays
combine tumor-and-normal profiling with proprietary algorithms to
deliver advanced insights even as cancer evolves over time. Our
products are designed to detect minimal residual disease (MRD) and
recurrence at the earliest timepoints, enable selection of targeted
therapies based on ultra-comprehensive genomic profiling, and
enhance biomarker strategy for drug development. Personalis is
based in Fremont, California. To learn more, visit
www.personalis.com and connect with us on LinkedIn and Twitter.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230829336058/en/
Investors: Caroline Corner investors@personalis.com
415-202-5678
Media: pr@personalis.com
Personalis (NASDAQ:PSNL)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025
Personalis (NASDAQ:PSNL)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025
